Pulmatrix, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pulmatrix, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2013 to Q4 2024.
  • Pulmatrix, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $13K, a 93.4% decline year-over-year.
  • Pulmatrix, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $511K, a 46.4% decline year-over-year.
  • Pulmatrix, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $511K, a 46.4% decline from 2023.
  • Pulmatrix, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $954K, a 14.4% decline from 2022.
  • Pulmatrix, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.11M, a 3.8% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $511K $13K -$184K -93.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-21
Q3 2024 $695K $197K -$9K -4.37% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $704K $103K -$152K -59.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $856K $198K -$98K -33.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $954K $197K -$82K -29.4% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-21
Q3 2023 $1.04M $206K -$71K -25.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $1.11M $255K -$22K -7.94% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $1.13M $296K +$15K +5.34% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $1.11M $279K +$32K +13% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $1.08M $277K -$7K -2.47% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.09M $277K -$22K -7.36% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.11M $281K -$47K -14.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $1.16M $247K +$1K +0.41% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $1.16M $284K -$19K -6.27% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.18M $299K +$33K +12.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $1.14M $328K -$15K -4.37% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.16M $246K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 $303K +$118K +63.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $266K -$825K -75.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $343K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $185K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $1.09M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2015 $452K $120K +$120K Jan 1, 2015 Mar 31, 2015 10-K 2015-06-10
Q4 2014 $332K $133K +$133K Oct 1, 2014 Dec 31, 2014 10-Q 2015-02-13
Q3 2014 $199K $133K +$133K Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-13
Q2 2014 $66K $66K +$66K Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $0 $0 Jan 1, 2014 Mar 31, 2014 10-K 2015-06-10
Q4 2013 $0 Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-13
Q3 2013 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $0 Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.